XML 40 R7.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statement of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash Flows From Operating Activities      
Net Income (Loss) $ 9,245,000,000 $ 10,957,000,000 $ 18,680,000,000
Adjustments to reconcile net income (loss) to net cash provided by operating activities      
Depreciation, depletion and amortization 9,599,000,000 8,270,000,000 7,504,000,000
Impairments 80,000,000 14,000,000 (12,000,000)
Dry hole costs and leasehold impairments 46,000,000 162,000,000 340,000,000
Accretion on discounted liabilities 325,000,000 283,000,000 250,000,000
Deferred taxes 367,000,000 1,145,000,000 2,086,000,000
Distributions more (less) than income from equity affiliates 564,000,000 964,000,000 942,000,000
(Gain) loss on dispositions (51,000,000) (228,000,000) (1,077,000,000)
(Gain) loss on investment in Cenovus Energy 0 0 (251,000,000)
Other 130,000,000 (220,000,000) 86,000,000
Working capital adjustments      
Decrease (increase) in accounts and notes receivable (262,000,000) 1,333,000,000 (963,000,000)
Decrease (increase) in inventories (68,000,000) (103,000,000) (38,000,000)
Decrease (increase) in prepaid expenses and other current assets 79,000,000 337,000,000 (173,000,000)
Increase (decrease) in accounts payable (543,000,000) (1,118,000,000) 901,000,000
Increase (decrease) in taxes and other accruals 613,000,000 (1,831,000,000) 39,000,000
Net Cash Provided by Operating Activities 20,124,000,000 19,965,000,000 28,314,000,000
Cash Flows From Investing Activities      
Capital expenditures and investments (12,118,000,000) (11,248,000,000) (10,159,000,000)
Working capital changes associated with investing activities 302,000,000 30,000,000 520,000,000
Acquisition of businesses, net of cash acquired (24,000,000) (2,724,000,000) (60,000,000)
Proceeds from asset dispositions 261,000,000 632,000,000 3,471,000,000
Net sales (purchases) of investments 415,000,000 1,373,000,000 (2,629,000,000)
Collection of advances/loans—related parties 0 0 114,000,000
Other 14,000,000 (63,000,000) 2,000,000
Net Cash Used in Investing Activities (11,150,000,000) (12,000,000,000) (8,741,000,000)
Cash Flows From Financing Activities      
Issuance of debt 5,591,000,000 3,787,000,000 2,897,000,000
Repayment of debt (4,981,000,000) (1,379,000,000) (6,267,000,000)
Issuance of company common stock (78,000,000) (52,000,000) 362,000,000
Repurchase of company common stock (5,463,000,000) (5,400,000,000) (9,270,000,000)
Dividends paid (3,646,000,000) (5,583,000,000) (5,726,000,000)
Other (258,000,000) (34,000,000) (49,000,000)
Net Cash Used in Financing Activities (8,835,000,000) (8,661,000,000) (18,053,000,000)
Effect of Exchange Rate Changes on Cash, Cash Equivalents and Restricted Cash (133,000,000) (99,000,000) (224,000,000)
Net Change in Cash, Cash Equivalents and Restricted Cash 6,000,000 (795,000,000) 1,296,000,000
Cash, cash equivalents and restricted cash at beginning of period [1] 5,899,000,000 6,694,000,000 5,398,000,000
Cash, Cash Equivalents and Restricted Cash at End of Period [1] $ 5,905,000,000 $ 5,899,000,000 $ 6,694,000,000
[1] Restricted cash of $298 million and $264 million is included in the “Other assets” line of our Consolidated Balance Sheet as of December 31, 2024 and December 31, 2023, respectively.